Re: Kimmo Kettunen,Peter J. Boström,Tarja Lamminen,et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430–4: Can Patient-derived Cancer Models Change the Costliest Cancer Type? 期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Re: Kimmo Kettunen,Peter J. Boström,Tarja Lamminen,et al. Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells. Eur Urol 2019;76:430–4: Can Patient-derived Cancer Models Change the Costliest Cancer Type?

摘要：
本文献已被 ScienceDirect 等数据库收录！